Showing results (1321-1330 of 5,989) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|February 13, 2015
The IGF-Trap: Novel Inhibitor of Carcinoma Growth and MetastasisNi Wang, Roni F Rayes, Seyyed Mehdy Elahi, et al.
Molecular Cancer Therapeutics|February 13, 2015
Dual PI3K/mTOR Inhibitors Induce Rapid Overactivation of the MEK/ERK Pathway in Human Pancreatic Cancer Cells through Suppression of mTORC2Heloisa P Soares, Ming Ming, Michelle Mellon, et al.
Molecular Cancer Therapeutics|February 13, 2015
Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast CancerArvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, et al.
Molecular Cancer Therapeutics|February 13, 2015
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR PathwaysMarieke Aarts, Ilirjana Bajrami, Maria T Herrera-Abreu, et al.
Molecular Cancer Therapeutics|February 13, 2015
Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activityRosemarie C D'Angelo, Maria Ouzounova, April Davis, et al.
Molecular Cancer Therapeutics|April 27, 2021
In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALLPouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Roddy S O'Connor
Molecular Cancer Therapeutics|April 21, 2021
BRAF V600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell HistiocytosisChan-Juan Wang, Lei Cui, Hong-Hao Ma, et al.
Molecular Cancer Therapeutics|April 21, 2021
Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma CellsMariko Ishibashi, Junichi Yamamoto, Takumi Ito, et al.
Molecular Cancer Therapeutics|April 14, 2021
Innate Immune Checkpoint Inhibitors: The Next Breakthrough in Medical Oncology?Robert W Lentz, Meryl D Colton, Siddhartha S Mitra, et al.
Molecular Cancer Therapeutics|October 18, 2012
Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxelDiana M Cittelly, Irina Dimitrova, Erin N Howe, et al.
Pageof 599